KLAC

SEC source: 0001181431-07-070546 · rrd179199.xml · nonDerivative · entry 1

BARNHOLT EDWARD W · CIK 0001142615 · Director · CHAIRMAN OF THE BOARD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,457

F1 · security: Each restricted stock unit represents a contingent right to receive one share of KLAC common stock.

F2 · price: The restricted stock units will fully vest one year from date of grant and will be deliverable on such date.

SEC source: 0001181431-07-070548 · rrd179198.xml · nonDerivative · entry 1

KAUFMAN STEPHEN P · CIK 0001186370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,971

F1 · security: Each restricted stock unit represents a contingent right to receive one share of KLAC common stock.

F2 · price: The restricted stock units will fully vest one year from date of grant and will be deliverable on such date.

SEC source: 0001181431-07-070549 · rrd179197.xml · nonDerivative · entry 1

Wang David C · CIK 0001363141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,467

F1 · security: Each restricted stock unit represents a contingent right to receive one share of KLAC common stock.

F2 · price: The restricted stock units will fully vest one year from date of grant and will be deliverable on such date.

SEC source: 0001181431-07-070551 · rrd179196.xml · nonDerivative · entry 1

URBANEK LIDA · CIK 0000929927 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,971

F1 · security: Each restricted stock unit represents a contingent right to receive one share of KLAC common stock.

F2 · price: The restricted stock units will fully vest one year from date of grant and will be deliverable on such date.

SEC source: 0001181431-07-070552 · rrd179193.xml · nonDerivative · entry 1

BOND ROBERT T · CIK 0001186083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,971

F1 · security: Each restricted stock unit represents a contingent right to receive one share of KLAC common stock.

F2 · price: The restricted stock units will fully vest one year from date of grant and will be deliverable on such date.

SEC source: 0001181431-07-070554 · rrd179192.xml · nonDerivative · entry 1

BINGHAM H RAYMOND · CIK 0001181467 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,971

F1 · security: Each restricted stock unit represents a contingent right to receive one share of KLAC common stock.

F2 · price: The restricted stock units will fully vest one year from date of grant and will be deliverable on such date.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 12

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,896

Underlying: Common Stock · 1,896 shares

Expires 2012-11-08

F12 · kind: On November 8, 2002, the reporting person was granted an option to purchase 3,250 shares of the Issuer's Common Stock at a purchase price of $37.05 per share. The actual grant date was subsequently determined to be November 18, 2002. Had the option been granted at fair market value on November 18, 2002, the exercise price of the option would have been $37.43 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,896 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($37.43) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 13)

F13 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,354 shares at the original exercise price of $37.05 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F12 · price: On November 8, 2002, the reporting person was granted an option to purchase 3,250 shares of the Issuer's Common Stock at a purchase price of $37.05 per share. The actual grant date was subsequently determined to be November 18, 2002. Had the option been granted at fair market value on November 18, 2002, the exercise price of the option would have been $37.43 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,896 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($37.43) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 13)

F13 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,354 shares at the original exercise price of $37.05 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 11

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,896 shares

Expires 2012-11-08

F12 · kind: On November 8, 2002, the reporting person was granted an option to purchase 3,250 shares of the Issuer's Common Stock at a purchase price of $37.05 per share. The actual grant date was subsequently determined to be November 18, 2002. Had the option been granted at fair market value on November 18, 2002, the exercise price of the option would have been $37.43 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,896 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($37.43) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 13)

F13 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,354 shares at the original exercise price of $37.05 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F12 · price: On November 8, 2002, the reporting person was granted an option to purchase 3,250 shares of the Issuer's Common Stock at a purchase price of $37.05 per share. The actual grant date was subsequently determined to be November 18, 2002. Had the option been granted at fair market value on November 18, 2002, the exercise price of the option would have been $37.43 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,896 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($37.43) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 13)

F13 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,354 shares at the original exercise price of $37.05 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 10

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,700

Underlying: Common Stock · 7,700 shares

Expires 2011-10-02

F10 · kind: On October 2, 2001, the reporting person was granted an option to purchase 21,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 25, 2001. Had the option been granted at fair market value on October 25, 2001, the exercise price of the option would have been $45.25 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 7,700 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($45.25) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 11)

F11 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 800 shares at the original exercise price of $29.31 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F10 · price: On October 2, 2001, the reporting person was granted an option to purchase 21,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 25, 2001. Had the option been granted at fair market value on October 25, 2001, the exercise price of the option would have been $45.25 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 7,700 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($45.25) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 11)

F11 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 800 shares at the original exercise price of $29.31 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 9

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,700 shares

Expires 2011-10-02

F10 · kind: On October 2, 2001, the reporting person was granted an option to purchase 21,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 25, 2001. Had the option been granted at fair market value on October 25, 2001, the exercise price of the option would have been $45.25 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 7,700 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($45.25) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 11)

F11 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 800 shares at the original exercise price of $29.31 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F10 · price: On October 2, 2001, the reporting person was granted an option to purchase 21,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 25, 2001. Had the option been granted at fair market value on October 25, 2001, the exercise price of the option would have been $45.25 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 7,700 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($45.25) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 11)

F11 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 800 shares at the original exercise price of $29.31 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 8

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,700

Underlying: Common Stock · 1,700 shares

Expires 2011-10-02

F9 · kind: On October 2, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 24, 2001. Had the option been granted at fair market value on October 24, 2001, the exercise price of the option would have been $40.86 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($40.86) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). The amendment is reported in this Form 4 as a cancellation of the option and the grant of a replacement option.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F9 · price: On October 2, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 24, 2001. Had the option been granted at fair market value on October 24, 2001, the exercise price of the option would have been $40.86 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($40.86) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). The amendment is reported in this Form 4 as a cancellation of the option and the grant of a replacement option.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 7

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,700 shares

Expires 2011-10-02

F9 · kind: On October 2, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 24, 2001. Had the option been granted at fair market value on October 24, 2001, the exercise price of the option would have been $40.86 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($40.86) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). The amendment is reported in this Form 4 as a cancellation of the option and the grant of a replacement option.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F9 · price: On October 2, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 24, 2001. Had the option been granted at fair market value on October 24, 2001, the exercise price of the option would have been $40.86 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($40.86) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). The amendment is reported in this Form 4 as a cancellation of the option and the grant of a replacement option.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 6

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 625

Underlying: Common Stock · 625 shares

Expires 2011-07-10

F7 · kind: On July 10, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 625 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 8)

F8 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 5,375 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F7 · price: On July 10, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 625 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 8)

F8 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 5,375 shares at the original exercise price of $46.67 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 5

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 625 shares

Expires 2011-07-10

F7 · kind: On July 10, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 625 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 8)

F8 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 5,375 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F7 · price: On July 10, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 625 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 8)

F8 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 5,375 shares at the original exercise price of $46.67 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 4

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,046

Underlying: Common Stock · 1,046 shares

Expires 2011-07-10

F5 · kind: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,046 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 6)

F6 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,657 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F5 · price: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,046 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 6)

F6 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,657 shares at the original exercise price of $46.67 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 3

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,046 shares

Expires 2011-07-10

F5 · kind: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,046 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 6)

F6 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,657 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F5 · price: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,046 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 6)

F6 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,657 shares at the original exercise price of $46.67 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 2

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,521

Underlying: Common Stock · 1,521 shares

Expires 2011-07-10

F1 · kind: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,521 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51).(Continue with footnote 2)

F2 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 4,182 shares at the original exercise price of $46.67 per share.

F1 · price: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,521 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51).(Continue with footnote 2)

F2 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 4,182 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 1

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,521 shares

Expires 2011-07-10

F1 · kind: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,521 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51).(Continue with footnote 2)

F2 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 4,182 shares at the original exercise price of $46.67 per share.

F1 · price: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,521 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51).(Continue with footnote 2)

F2 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 4,182 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-065566 · rrd176565.xml · derivative · entry 1

BINGHAM H RAYMOND · CIK 0001181467 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-10-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-065567 · rrd176569.xml · derivative · entry 1

BOND ROBERT T · CIK 0001186083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-10-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-065569 · rrd176576.xml · derivative · entry 1

KAUFMAN STEPHEN P · CIK 0001186370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-10-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-065571 · rrd176568.xml · derivative · entry 1

Wang David C · CIK 0001363141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-10-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-065573 · rrd176572.xml · derivative · entry 1

URBANEK LIDA · CIK 0000929927 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-10-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-065576 · rrd176574.xml · derivative · entry 1

CALDERONI ROBERT · CIK 0001183228 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-10-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-065577 · rrd176567.xml · derivative · entry 1

BARNHOLT EDWARD W · CIK 0001142615 · Director · CHAIRMAN OF THE BOARD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2014-10-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-065578 · rrd176573.xml · derivative · entry 1

DICKSON JOHN T · CIK 0001207927 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-10-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-065579 · rrd176570.xml · derivative · entry 1

KENNEDY KEVIN · CIK 0001182379 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-10-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-051763 · rrd169143.xml · nonDerivative · entry 1

Titinger Jorge · CIK 0001385162 · SVP,Chief Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,600

F1 · security: On September 19, 2006, the Reporting Person was granted a restricted stock unit covering up to 25,000 shares of the Issuer's Common Stock which are subject to both performance-vesting and service-vesting requirements. Following the completion of the Issuer's audited financial statements for the 2007 fiscal year, the Issuer's Board of Directors determined on August 8, 2007 the level at which the performance goals were attained, and based on that assessment, determined that the number of shares subject to the restricted stock units is 25,000. The Reporting Person will vest in 50% of the restricted stock units upon his completion of two years of service with the Issuer measured from September 19, 2006 and will vest in the remaining 50% upon his completion of an additional two years of service thereafter. The shares of common stock will be issued as the restricted stock units vest.

F1 · shares: On September 19, 2006, the Reporting Person was granted a restricted stock unit covering up to 25,000 shares of the Issuer's Common Stock which are subject to both performance-vesting and service-vesting requirements. Following the completion of the Issuer's audited financial statements for the 2007 fiscal year, the Issuer's Board of Directors determined on August 8, 2007 the level at which the performance goals were attained, and based on that assessment, determined that the number of shares subject to the restricted stock units is 25,000. The Reporting Person will vest in 50% of the restricted stock units upon his completion of two years of service with the Issuer measured from September 19, 2006 and will vest in the remaining 50% upon his completion of an additional two years of service thereafter. The shares of common stock will be issued as the restricted stock units vest.

SEC source: 0001181431-07-051764 · rrd169142.xml · nonDerivative · entry 1

WALLACE RICHARD P · CIK 0001196898 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,661

F1 · security: On September 19, 2006, the Reporting Person was granted a restricted stock unit covering up to 62,500 shares of the Issuer's Common Stock which are subject to both performance-vesting and service-vesting requirements. Following the completion of the Issuer's audited financial statements for the 2007 fiscal year, the Issuer's Board of Directors determined on August 8, 2007 the level at which the performance goals were attained, and based on that assessment, determined that the number of shares subject to the restricted stock units is 62,500. The Reporting Person will vest in 50% of the restricted stock units upon his completion of two years of service with the Issuer measured from September 19, 2006 and will vest in the remaining 50% upon his completion of an additional two years of service thereafter. The shares of common stock will be issued as the restricted stock units vest.

F1 · shares: On September 19, 2006, the Reporting Person was granted a restricted stock unit covering up to 62,500 shares of the Issuer's Common Stock which are subject to both performance-vesting and service-vesting requirements. Following the completion of the Issuer's audited financial statements for the 2007 fiscal year, the Issuer's Board of Directors determined on August 8, 2007 the level at which the performance goals were attained, and based on that assessment, determined that the number of shares subject to the restricted stock units is 62,500. The Reporting Person will vest in 50% of the restricted stock units upon his completion of two years of service with the Issuer measured from September 19, 2006 and will vest in the remaining 50% upon his completion of an additional two years of service thereafter. The shares of common stock will be issued as the restricted stock units vest.

SEC source: 0001181431-07-051765 · rrd169140.xml · nonDerivative · entry 1

KISPERT JOHN H · CIK 0001183250 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,833

F1 · security: On September 19, 2006, the Reporting Person was granted a restricted stock unit covering up to 62,500 shares of the Issuer's Common Stock which are subject to both performance-vesting and service-vesting requirements. Following the completion of the Issuer's audited financial statements for the 2007 fiscal year, the Issuer's Board of Directors determined on August 8, 2007 the level at which the performance goals were attained, and based on that assessment, determined that the number of shares subject to the restricted stock units is 62,500. The Reporting Person will vest in 50% of the restricted stock units upon his completion of two years of service with the Issuer measured from September 19, 2006 and will vest in the remaining 50% upon his completion of an additional two years of service thereafter. The shares of common stock will be issued as the restricted stock units vest.

F1 · shares: On September 19, 2006, the Reporting Person was granted a restricted stock unit covering up to 62,500 shares of the Issuer's Common Stock which are subject to both performance-vesting and service-vesting requirements. Following the completion of the Issuer's audited financial statements for the 2007 fiscal year, the Issuer's Board of Directors determined on August 8, 2007 the level at which the performance goals were attained, and based on that assessment, determined that the number of shares subject to the restricted stock units is 62,500. The Reporting Person will vest in 50% of the restricted stock units upon his completion of two years of service with the Issuer measured from September 19, 2006 and will vest in the remaining 50% upon his completion of an additional two years of service thereafter. The shares of common stock will be issued as the restricted stock units vest.

SEC source: 0001181431-07-051766 · rrd169139.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,750

F1 · security: On September 19, 2006, the Reporting Person was granted a restricted stock unit covering up to 18,750 shares of the Issuer's Common Stock which are subject to both performance-vesting and service-vesting requirements. Following the completion of the Issuer's audited financial statements for the 2007 fiscal year, the Issuer's Board of Directors determined on August 8, 2007 the level at which the performance goals were attained, and based on that assessment, determined that the number of shares subject to the restricted stock units is 18,750. The Reporting Person will vest in 50% of the restricted stock units upon his completion of two years of service with the Issuer measured from September 19, 2006 and will vest in the remaining 50% upon his completion of an additional two years of service thereafter. The shares of common stock will be issued as the restricted stock units vest.

F1 · shares: On September 19, 2006, the Reporting Person was granted a restricted stock unit covering up to 18,750 shares of the Issuer's Common Stock which are subject to both performance-vesting and service-vesting requirements. Following the completion of the Issuer's audited financial statements for the 2007 fiscal year, the Issuer's Board of Directors determined on August 8, 2007 the level at which the performance goals were attained, and based on that assessment, determined that the number of shares subject to the restricted stock units is 18,750. The Reporting Person will vest in 50% of the restricted stock units upon his completion of two years of service with the Issuer measured from September 19, 2006 and will vest in the remaining 50% upon his completion of an additional two years of service thereafter. The shares of common stock will be issued as the restricted stock units vest.

SEC source: 0001181431-07-049248 · rrd167895.xml · derivative · entry 1

DICKSON JOHN T · CIK 0001207927 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2017-07-31

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-049249 · rrd167856.xml · derivative · entry 1

CALDERONI ROBERT · CIK 0001183228 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2017-07-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-049251 · rrd167852.xml · derivative · entry 1

KAUFMAN STEPHEN P · CIK 0001186370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2017-07-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-049252 · rrd167850.xml · derivative · entry 1

BOND ROBERT T · CIK 0001186083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2017-07-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-049255 · rrd167848.xml · derivative · entry 1

BINGHAM H RAYMOND · CIK 0001181467 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2017-07-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-049256 · rrd167845.xml · derivative · entry 1

URBANEK LIDA · CIK 0000929927 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2017-07-30

F1 · derivative.exercise_date: Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-049258 · rrd167842.xml · derivative · entry 1

BARNHOLT EDWARD W · CIK 0001142615 · Director · CHAIRMAN OF THE BOARD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2017-07-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-049259 · rrd167841.xml · derivative · entry 1

Wang David C · CIK 0001363141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2017-07-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-049260 · rrd167836.xml · derivative · entry 1

KENNEDY KEVIN · CIK 0001182379 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2017-07-30

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

SEC source: 0001181431-07-065536 · rrd176729.xml · derivative · entry 1

BINGHAM H RAYMOND · CIK 0001181467 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-07-31

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

F2 · derivative.expiration_date: The Option expiration date was reported incorrectly on the original Form 4.

SEC source: 0001181431-07-065540 · rrd176724.xml · derivative · entry 1

BOND ROBERT T · CIK 0001186083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-07-31

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

F2 · derivative.expiration_date: The Option expiration date was reported incorrectly on the original Form 4.

SEC source: 0001181431-07-065545 · rrd176743.xml · derivative · entry 1

KAUFMAN STEPHEN P · CIK 0001186370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-07-31

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

F2 · derivative.expiration_date: The Option expiration date was reported incorrectly on the original Form 4.

SEC source: 0001181431-07-065546 · rrd176751.xml · derivative · entry 1

Wang David C · CIK 0001363141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-07-31

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

F2 · derivative.expiration_date: The Option expiration date was reported incorrectly on the original Form 4.

SEC source: 0001181431-07-065548 · rrd176731.xml · derivative · entry 1

URBANEK LIDA · CIK 0000929927 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-07-31

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

F2 · derivative.expiration_date: The Option expiration date was reported incorrectly on the original Form 4.

SEC source: 0001181431-07-065549 · rrd176744.xml · derivative · entry 1

CALDERONI ROBERT · CIK 0001183228 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-07-31

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

F2 · derivative.expiration_date: The Option expiration date was reported incorrectly on the original Form 4.

SEC source: 0001181431-07-065550 · rrd176740.xml · derivative · entry 1

BARNHOLT EDWARD W · CIK 0001142615 · Director · CHAIRMAN OF THE BOARD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2014-07-31

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

F2 · derivative.expiration_date: The Option expiration date was reported incorrectly on the original Form 4.

SEC source: 0001181431-07-065552 · rrd176720.xml · derivative · entry 1

DICKSON JOHN T · CIK 0001207927 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-07-31

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

F2 · derivative.expiration_date: The Option expiration date was reported incorrectly on the original Form 4.

SEC source: 0001181431-07-065553 · rrd176736.xml · derivative · entry 1

KENNEDY KEVIN · CIK 0001182379 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2014-07-31

F1 · derivative.exercise_date: The Option is immediately exercisable for all the underlying shares.

F2 · derivative.expiration_date: The Option expiration date was reported incorrectly on the original Form 4.

SEC source: 0001181431-07-046811 · rrd166509.xml · derivative · entry 2

URBANEK LIDA · CIK 0000929927 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2007-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options were originally granted for 5,000 shares of the Issuer's common stock and were immediately excercisable for all the underlying shares on the date of grant.